Revenue for the quarter was $49,000 with operating income of $4.30 million.
The Ocala, Florida (FL)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $34.99 million.
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here. 
